These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6808306)

  • 41. GM1-Gangliosidosis: a molecular abnormality of acid beta-galactosidase in fibroblasts.
    Furuya T; Suzuki Y
    J Inherit Metab Dis; 1984; 7(3):145-6. PubMed ID: 6438402
    [No Abstract]   [Full Text] [Related]  

  • 42. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease.
    Pernber Z; Blennow K; Bogdanovic N; Månsson JE; Blomqvist M
    Dement Geriatr Cogn Disord; 2012; 33(2-3):174-88. PubMed ID: 22572791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occurrence of glycosylation and deglycosylation of exogenously administered ganglioside GM1 in mouse liver.
    Ghidoni R; Sonnino S; Chigorno V; Venerando B; Tettamanti G
    Biochem J; 1983 Aug; 213(2):321-9. PubMed ID: 6615438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Facile method for the preparation of lyso-GM1 and lyso-GM2.
    Ando T; Li SC; Ito M; Li YT
    J Chromatogr A; 2005 Jun; 1078(1-2):193-5. PubMed ID: 16010718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ferret pyramidal cell dendritogenesis: changes in morphology and ganglioside expression during cortical development.
    Zervas M; Walkley SU
    J Comp Neurol; 1999 Oct; 413(3):429-48. PubMed ID: 10502250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gangliosides in acetylcholine receptor-rich membranes from Torpedo marmorata and Discopyge tschudii.
    Marcheselli V; Daniotti JL; Vidal AC; Maccioni H; Marsh D; Barrantes FJ
    Neurochem Res; 1993 May; 18(5):599-603. PubMed ID: 8474578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A protein activator for the enzymic hydrolysis of GM2 ganglioside.
    Li SC; Hirabayashi Y; Li YT
    J Biol Chem; 1981 Jun; 256(12):6234-40. PubMed ID: 7240201
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular pathology of gangliosidoses.
    Tettamanti G; Berra B; di Palma S
    Biochem Exp Biol; 1977; 13(1):101-27. PubMed ID: 418789
    [No Abstract]   [Full Text] [Related]  

  • 49. Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b.
    Riboni L; Ghidoni R; Tettamanti G
    J Neurochem; 1989 May; 52(5):1401-6. PubMed ID: 2709011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of new ganglioside probes and unraveling of raft domain structure by single-molecule imaging.
    Suzuki KGN; Ando H; Komura N; Fujiwara TK; Kiso M; Kusumi A
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2494-2506. PubMed ID: 28734966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage.
    Seyrantepe V; Canuel M; Carpentier S; Landry K; Durand S; Liang F; Zeng J; Caqueret A; Gravel RA; Marchesini S; Zwingmann C; Michaud J; Morales CR; Levade T; Pshezhetsky AV
    Hum Mol Genet; 2008 Jun; 17(11):1556-68. PubMed ID: 18270209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.
    Kohyama M; Yabuki A; Ochiai K; Nakamoto Y; Uchida K; Hasegawa D; Takahashi K; Kawaguchi H; Tsuboi M; Yamato O
    BMC Vet Res; 2016 Mar; 12():67. PubMed ID: 27036194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calculation of the conformation of glycosphingolipids. 2. GM1- and GM2-gangliosides.
    Wynn CH; Robson B
    J Theor Biol; 1986 Nov; 123(2):221-30. PubMed ID: 3626589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1.
    Larsson EA; Olsson U; Whitmore CD; Martins R; Tettamanti G; Schnaar RL; Dovichi NJ; Palcic MM; Hindsgaul O
    Carbohydr Res; 2007 Feb; 342(3-4):482-9. PubMed ID: 17069778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.
    Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of a GM1 ganglioside beta-galactosidase microassay method to diagnosis of GM1 gangliosidosis.
    Mutoh T; Kiuchi K; Sobue I; Naoi M
    Clin Chim Acta; 1984 Jul; 140(3):223-30. PubMed ID: 6432371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alterations in ganglioside expression during the differentiation of human mast cells.
    Zuberbier T; Guhl S; Hantke T; Hantke C; Welker P; Grabbe J; Henz BM
    Exp Dermatol; 1999 Oct; 8(5):380-7. PubMed ID: 10536964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain gangliosides of quaking and shiverer mutants: qualitative and quantitative changes of monosialogangliosides in the quaking brain.
    Iwamori M; Harpin ML; Lachapelle F; Baumann N
    J Neurochem; 1985 Jul; 45(1):73-8. PubMed ID: 3998734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Approaches in the study of ganglioside metabolism.
    Tettamanti G; Ghidoni R; Sonnino S; Chigorno V; Venerando B; Giuliani A; Fiorilli A
    Adv Exp Med Biol; 1984; 174():273-84. PubMed ID: 6377848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GM1 gangliosidosis: phenotypic variation in a single family.
    Farrell DF; Ochs U
    Ann Neurol; 1981 Mar; 9(3):225-31. PubMed ID: 6784662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.